Winston Peters has signalled the Gene Technology Bill NZ is unlikely to pass in the current term, sharpening focus on coalition priorities in Wellington and the timeline for gene technology legislation in the New Zealand Parliament. The NZ First leader told Farmers Weekly the bill is “unlikely to pass this term”, setting expectations for farmers and regulators looking for clarity on gene technology rules.

Coalition timing and parliamentary risk

Peters’ statement places the bill’s progress squarely in the hands of coalition negotiations, where competing policy agendas can stall complex reforms. As deputy prime minister in a National‑ACT‑NZ First Government, he holds leverage over the legislative programme, and his caution signals that timing, not just policy design, is a hurdle.

The Gene Technology Bill is intended to modernise New Zealand’s regulatory settings, but a delay would extend uncertainty over how new tools are assessed and approved. For the Government, the risk is credibility on delivering promised reforms; for opponents, the delay keeps the current safeguards in place longer.

What it means for the sector

Farming and biotech stakeholders have been awaiting a clearer pathway on gene technology, seeing it as critical for productivity and resilience. Peters’ comments suggest the sector may have to plan around a slower timeline, while officials continue to weigh public trust and regulatory safeguards.

The bill’s fate now underscores the broader balance of power within the coalition and the political sensitivity around gene technology, with the longer-term implication being that regulatory change in New Zealand remains deeply tied to coalition stability and public confidence.